Search Results | Showing 1 - 10 of 14 results for "Brandon Capital" |
| | | Brandon Capital, a life sciences venture capital firm has exited from its investment in Myricx Bio, following its agreement to be acquired by Novartis for US$1.5 billion ($2.2bn). The exit will generate a significant return for investors, Brandon Capital ... |
| | | | ... its investing spree specifically in the venture capital space, injecting undisclosed amounts in Tidal Ventures, Brandon Capital, and Sprint Ventures. Its Queensland Venture Capital Development Fund is currently funding an accelerator program that trains ... |
| | | | ... investor in early and growth-stage fund Sprint Ventures, while also investing in biotech venture capital firm Brandon Capital. Yesterday, Financial Standard reported that QIC's venture capital development fund (QVCDF) committed funds to technology investment ... |
| | | | ... later, V-Ignite has been selected by the Victorian government to run its newly created VSCF alongside VC investor Brandon Capital Partners. V-Ignite is tasked with raising at least $60 million from private investors including super funds, family offices ... |
| | | | ... firm has raised $11.7 million, led by the Medical Research Commercialisation Fund (MCRF), which is managed by Brandon Capital and other investment partners that includes federal government support via MCRF and superannuation funds. The preventative nasal ... |
| | | | ... Respiratory raised $11.7 million from a coalition of institutional Australian investors in a capital raise led by Brandon Capital, a venture capital firm that manages the Medical Research Commercialisation Fund; Australia and New Zealand's largest life ... |
| | | | ... private equity and early stage investment firms, including Blackbird Ventures ($160m), Carthona Capital ($50m), Brandon Capital ($40m), Siguler Guff ($20m) and M.H. Carnegie ($25m). "That makes Hostplus by the far the largest investor in venture capital ... |
| | | | ... US$557.5 million. Fibrotech was an investee company of the Medical Research Commercialisation Fund managed by Brandon Capital Partners, with its investors comprising Australian Super, Statewide Super, HESTA, Hostplus and the Australian Government. In ... |
| | | | ... development. This follows a long line of venture capital investments made by Hostplus, including commitments to Brandon Capital, Blackbird Ventures and Square Peg Capital. Speaking to the investment from Hostplus, Artesian managing partner Jeremy Colless ... |
| | | | Brandon Capital will lead a group of venture capital firms tasked with managing the government's $500 million Biomedical Translation Fund (BTF). Brandon Capital will drive the development of its life sciences fund, the Medical Research Commercialisation ... |
|